07:00 , May 9, 2016 |  BC Week In Review  |  Financial News

Homology Medicines completes venture financing

Homology Medicines Inc. , Lexington, Mass.   Business: Hematology, Endocrine/Metabolic, Neurology   Date completed: 2016-05-02   Type: Venture financing   Raised: $43.5 million   Investors: 5AM Ventures; Arch Venture Partners; Deerfield Management; Temasek; Arch Overage...
01:35 , May 3, 2016 |  BC Extra  |  Financial News

5AM incubator spinout Homology raises $43.5M

Gene editing company Homology Medicines Inc. spun out of 5AM Ventures' incubator with a $43.5 million series A round led by 5AM and Arch Venture Partners. Temasek, Deerfield and Arch Overage Fund also participated. Homology's...
07:00 , Mar 28, 2016 |  BC Week In Review  |  Financial News

Quanterix completes venture financing

Quanterix Corp. , Lexington, Mass.   Business: Diagnostic, Supply/Service   Date completed: 2016-03-23   Type: Venture financing   Raised: $46 million   Investors: Arch Overage Fund; Cormorant Asset Management; Trinitas Capital; Arch Venture Partners; Bain...
00:58 , Mar 24, 2016 |  BC Extra  |  Financial News

Quanterix raises $46M in D round

Diagnostic play Quanterix Corp. (Lexington, Mass.) raised $46 million in a series D round led by new investors Arch Overage Fund, Cormorant Asset Management and Trinitas Capital. Existing investors Arch Venture Partners, Bain Capital Ventures,...
08:00 , Jan 25, 2016 |  BioCentury  |  Finance

Platform Twist

Backers of Twist Bioscience Corp. believe the DNA synthesis company can grow to be the next Illumina Inc. (NASDAQ:ILMN). They might not have to wait long to see whether the public markets agree, as last...
08:00 , Jan 25, 2016 |  BC Week In Review  |  Financial News

Twist Bioscience completes venture financing

Twist Bioscience Corp. , San Francisco, Calif.   Business: Biomanufacturing, Supply/Service   Date completed: 2016-01-19   Type: Venture financing   Raised: $61 million   Investors: Arch Overage Fund; Merieux Developpement; Cormorant Asset Management; Fidelity; Foresite...
02:11 , Jan 20, 2016 |  BC Extra  |  Financial News

Twist raises $61M in series D

Twist Bioscience Corp. (San Francisco, Calif.) raised $61 million in a series D round. New investors WuXi Healthcare Ventures, Arch Overage Fund, Merieux Developpement, Cormorant Asset Management and Boris Nikolic joined existing investors Arch Venture...